Challenge accepted: Confronting readmissions for our patients with cirrhosis
Author:
Affiliation:
1. Division of Gastroenterology/Hepatology; Department of Medicine; Beth Israel Deaconess Medical Center, Harvard Medical School; Boston MA
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.28471/fullpdf
Reference11 articles.
1. Hospital readmissions among patients with decompensated cirrhosis;Volk;Am J Gastroenterol,2012
2. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis;Tapper;Hepatology,2015
3. The three-month readmission rate remains unacceptably high in a large north american cohort of cirrhotic patients;Bajaj;Hepatology,2016
4. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American Consortium for the study of end-stage liver disease (NACSELD) experience;Bajaj;Hepatology,2012
5. Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function;Bajaj;Am J Physiol Gastrointest Liver Physiol,2014
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bibliometrics and knowledge mapping of the pathogenesis of hepatic encephalopathy in patients with liver cirrhosis;Heliyon;2024-08
2. A randomized multicenter trial of a chronic disease management intervention for decompensated cirrhosis. The Australian Liver Failure (ALFIE) trial;Hepatology;2024-03-27
3. Applying human-centered design to the construction of a cirrhosis management clinical decision support system;Hepatology Communications;2024-02-26
4. Clinical decision support and electronic interventions to improve care quality in chronic liver diseases and cirrhosis;Hepatology;2023-08-23
5. Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium;The Lancet Gastroenterology & Hepatology;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3